19 May 2013
Keywords: new, biotech, products, csl, plant, australia, set
Article | 27 September 1999
CSL of Australia is set to develop new biotechnology treatments forulcers and stomach cancer at its new A$14 million ($8.9 million) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.